Health Care Facilities Stocks Review - HCA Holdings, Tenet Healthcare, Community Health Systems, Universal Health Services, and VCA Inc.

Editor Note: For more information about this release, please scroll to bottom.

LONDON, November 10, 2014 /PRNewswire/ --

Investor-Edge has initiated coverage on the following equities: HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corporation (NYSE: THC), Community Health Systems Inc. (NYSE: CYH), Universal Health Services Inc. (NYSE: UHS), and VCA Inc. (NASDAQ: WOOF). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 07, 2014, the NASDAQ Composite ended at 4,632.53, down 0.13%, the Dow Jones Industrial Average advanced 0.11%, to finish the day at 17,573.93, and the S&P 500 closed at 2,031.92, up 0.03%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 775.27, down 0.94%, while the index has advanced 10.75% in the previous three months. Register for your complimentary reports on these five stocks at:  

http://investor-edge.com/register

On Friday, shares in HCA Holdings Inc. traded between $64.30 and $69.11 before ending the session 4.67% lower at $65.75. The stock reported a trading volume of 13.83 million shares, much above its three months average volume of 3.42 million shares. Shares of the company traded at a PE ratio of 15.25. HCA Holdings Inc.'s shares have declined 5.18% in the previous three trading sessions and 2.06% in the last three months. However, the stock has surged 37.81% on YTD basis. The company's stock is trading above its 200-day moving average of $58.68. Moreover, shares of HCA Holdings Inc. have a Relative Strength Index (RSI) of 37.36. Sign up and read the free notes on HCA at:

www.Investor-Edge.com/HCA-10Nov2014

Tenet Healthcare Corp.'s stock plummeted 6.51%, to close the day at $47.85. The stock recorded a trading volume of 7.84 million shares, much above its three months average volume of 1.71 million shares. The stock oscillated between $47.38 and $51.27 during the session. Over the last three trading sessions and over the past three months, Tenet Healthcare Corp.'s shares have declined 9.82% and 15.80%, respectively. However, the stock has gained 13.60% since the start of this year. The company's stock is trading below its 50-day and 200-day moving averages. The stock's 50-day moving average of $58.18 is above its 200-day moving average of $49.72. Additionally, Tenet Healthcare Corp.'s stock traded at a PE ratio of 49.00 and has an RSI of 25.00. The complimentary notes on THC can be downloaded as in PDF format at:

www.Investor-Edge.com/THC-10Nov2014

On Friday, shares in Community Health Systems Inc. recorded a trading volume of 6.91 million shares, higher than its three months average volume of 1.61 million shares. The stock ended the day at $47.81, which was 5.51% below its previous day's closing of $50.60, and registered an intraday range of $46.17 and $50.64. Shares of the company traded at a PE ratio of 28.18. Community Health Systems Inc.'s shares have lost 8.45% in the previous three trading sessions and 0.89% in the last three months. However, the stock has surged 21.75% on YTD basis. The company's stock is trading above its 200-day moving average of $45.20. Furthermore, the shares of Community Health Systems Inc. have an RSI of 32.26. On November 07, 2014, Community Health Systems Inc. announced definitive agreement to divest Gadsden, Alabama hospital. Register for free on Investor-Edge and access the latest research on CYH at:

www.Investor-Edge.com/CYH-10Nov2014

Universal Health Services Inc.'s stock declined 2.31%, to close Friday's session at $97.93, after oscillating between $95.63 and $100.31. The stock recorded a trading volume of 2.94 million shares, above its three months average volume of 1.21 million shares. Over the last three trading sessions and the last one month, Universal Health Services Inc.'s shares have declined 4.08% and 9.47%, respectively. However, the stock has gained 20.51% on YTD basis. The company's stock is trading above its 200-day moving average of $93.67, while the 200-day moving average is below Universal Health Services Inc. stock's 50-day moving average of $107.38. Further, the stock traded at a PE ratio of 19.13 and has an RSI of 35.29. The complete research on UHS is available for free at:

www.Investor-Edge.com/UHS-10Nov2014

VCA Inc.'s stock finished Friday's session 1.87% lower at $45.85. A total of 0.64 million shares were traded, which was below its three months average volume of 0.76 million shares. The stock moved between $45.78 and $46.97 during the session. VCA Inc.'s shares have surged 15.35% in the last one month and 23.15% in the previous three months. Additionally, from the beginning of 2014, the stock has gained an upside of 46.21%. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $41.25 is greater than its 200-day moving average of $35.66. VCA Inc.'s stock traded at a PE ratio of 27.01 and has an RSI of 70.92. Free in depth research on WOOF is available at:

www.Investor-Edge.com/WOOF-10Nov2014

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.